On-line AppliTek TN/TP analyser. Click here to enlarge imageAt a pharmaceutical plant in Belgium no nitrification and denitrification of wastewater is carried out. Instead, an external C-source is dosed in the influent to have an optimum N-incorporation in the biomass to decrease N-concentration in effluent. The dosing of the external C-source is controlled and optimised via the measurement of different parameters like TOC and toxicity in the influent, and TN, TP and TOC in the effluent.
TOC in the influent is measured at the outcome of the primary and secondary clarifier (near dosing point C-source) and this value determines the action of the local feedback controller for the dosing pump of the external C-source.
The quality of the external C-source needs to be controlled by detecting the effects of a toxic or less biodegradable C-source. If toxicity is detected, an alarm should help avoid the biosystems going down. At this plant the on-line toxicity analyser Ra-BOD® (see further) acts as an early warning system to prevent intoxication of the biomass and to protect the treatment process. In the case of only off-line toxicity analysis, the biomass could already have been affected before the results were ready.
Finally, the quality of treated wastewater is controlled by several on-line analysers, including TONI®, for TN, TOPHO®, for TP and a TOC analyser1. The P-signal is used to control the automatic dosing of FeCl3 in order to precipitate the excess of ortho-phosphate as FePO4. In this way, the P-concentration in the effluent will not exceed the norm.
The N- and TOC-signal of the effluent are also used to control the dosing of the external C-source and consequently the N-incorporation in the biomass. These values are used as inputs in a "fuzzy supervisory control system," which determines the action of the dosing pump. In this control system, both signals are evaluated and several possibilities are checked before any action occurs.
Author's note
President and CEO David Laurier, M. Sc., and Applications/R&D Manager Kristof De Neve, Ph.D. work at AppliTek Inc., based in Deinze, Belgium.